| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |